Trial
NCT04305457
Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Massachusetts General Hospital
Collaborators
University of Alabama at Birmingham
Condition
Coronavirus Infections
Intervention
Nitric Oxide
Why stopped
COVID wave passed
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-23